title: Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets.
abstract: We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P < 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P < 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.
authors.affiliation: Department of Experimental Surgery-Transplantation Laboratory, Federal University of San Paolo, Brazil.
authors.forename: A B
authors.initials: AB
authors.lastname: Neto
authors.forename: E
authors.initials: E
authors.lastname: Haapalainen
authors.forename: R
authors.initials: R
authors.lastname: Ferreira
authors.forename: C F
authors.initials: CF
authors.lastname: Feo
authors.forename: E P
authors.initials: EP
authors.lastname: Misiako
authors.forename: G
authors.initials: G
authors.lastname: Vennarecci
authors.forename: A
authors.initials: A
authors.lastname: Porcu
authors.forename: S A
authors.initials: SA
authors.lastname: Dib
authors.forename: S
authors.initials: S
authors.lastname: Goldenberg
authors.forename: P O
authors.initials: PO
authors.lastname: Gomes
authors.forename: A T
authors.initials: AT
authors.lastname: Nigro
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008854:Microscopy, Electron; D051381:Rats; D017208:Rats, Wistar
chemical_list: D007166:Immunosuppressive Agents; D007328:Insulin; D016572:Cyclosporine; D005947:Glucose